Nodarse HR, del Campo AR

Language: Spanish
References: 15
Page: 116-123
PDF size: 231.46 Kb.

ABSTRACT

Objective: to present five cases and to provide updated information on Staphylococcus aureus and its role in skin and soft parts conditions, as well as on the best management to be used in these cases.
Methods: areview of the existing state of knowledge on Methicillin-resistant Staphylococcus aureus and related to skin and soft tissues infection as well as its currently-proposed antibiotic treatment. As an example, five cases, treated in "Manuel Fajardo" Hospital, "Dr. Luis Díaz Soto" Hospital and "Juan Manuel Marquez" Hospital, were presented.
Results: skin and soft tissues Infections by this organism are common in our environment, and affect both sexes and different ages. They range from furunculosis to cellulitis and abscesses. Identification of methicillin-resistant Staphylococcus aureus is possible through conventional techniques such as cefoxitin disks. There is no good knowledge about the appropriate antibiotic treatment on these infections. Best results are achieved with the use of sulfaprim and tetracyclines.
Conclusions: there is a significant increase in the number of skin and soft tissue infections, in both community and inpatient cases in our environment, caused by strains of methicillin-resistant Staphylococcus aureus. The most effective treatment includes the use of sulfamethoxazole-trimethoprim (sulfaprim) or doxycycline, associated with surgical drainage of lesions.

REFERENCES

1. Weiss C, Kaminsky P, Boggs J, Ley C. Skin and soft-tissue infections in suburban primary care: epidemiology of methicillin-resistant Staphylococcus aureus and observations on abscess management. BMC Res Notes. 2011;7;4(1):33.

2. Anderson DJ, Sexton DJ, Kanafani ZA. Severe surgical site infection in community hospitals: epidemiology, key procedures and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28(9):1047-53.

3. Nodarse R. Detección de Staphylococcus aureus resistente a meticilina mediante disco de cefoxitina. Rev Cubana Med Mil. 2009;38(3-4); [citado: 29 enero 2013]. Disponible en: htp://scitelo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572009000300004&lng=es&nrm=iso

4. Bhattacharya D, Smith D. Differences in clinical and molecular characteristics of skin and soft tissue MRSA isolates between two hospitals in Northern California. J Clin Microbiol. 2007;45(6):1798-803.

5. Taguchi H. Panton-Valentine leucocidin-positive MRSA infection in patients at a tertiary care centre in Tokyo, Japan. J Hosp Infect. 2010;76(3):268-9.

6. Khawcharoenporn T, Tice AD, Grandinetti A, Chow D. Risk factors for community-associated methicillin-resistant Staphylococcus aureus cellulites and the value of recognition. Hawaii Med J. 2010;69(10):232-6.

7. Harris SR. Evolution of MRSA during Hospital Transmission and Intercontinental Spread. Science. 2010;327(5964):469-74.

8. Gueron D. Sonda de ADN para cribado rápido del SARM. Lab Méd en español. 2010;27(3):7.

9. Bennett K, Sharp SE. Rapid differentiation of methicillin-resisant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus from blood cultures by use of a direct cefoxitin disk diffusion test. J Clin Microbiol. 2008;46(11):3836-8.

10. Boutiba-Ban Boubaker. Evaluation of a cefoxitin disk diffusion test for the routine detection of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2004;10(8):762-5.

11. Odell CA. Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections. Curr Opin Pediatr. 2010;22(3):273-7.

12. Gould IM, Cauda R. Management of serious methicillin-resistant Staphylococcus aureus infections. What are the limits? Int J Antimicrob Agents. 2011;5:23.

13. Schraga E. How to treat skin infections, uncluding MRSA, in 2008. Medscape J Med. 2008;10(5):109.

14. Frei CR, Miller ML, Lewis JS , Lawson KA, Hunter JM, Oramasionwu CU, Talbert RL. Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections. J Am Board Fam Med. 2010;23(6):714-9.

15. Bordona J, Master RN, Clark RB, Duvvuri P. Methicillin-resistant Staphylococcus aureus resistance to non-b-lactam antimicrobials in the United States from 1996 to 2008. Diagn Microbiol Infect Dis. 2010;67:395-8.